Brompheniramine + Dextromethorphan + Phenylephrine
Indications
Relief of Cold Symptoms
Adult Dose
Oral
Relief of Cold Symptoms
4 teaspoons (20 mL) 4 hourly; not to exceed 120 mL/24 hr
Child Dose
Oral
Relief of Cold Symptoms
<6 years
Not recommended
6-12 years
2 teaspoons (10 mL) PO 4 hourly
>12 years
4 teaspoons (20 mL) PO 4 hourly
Contra Indications
Contraindications
Hypersensitivity
Newborn infants, premature infants
Nursing mothers
Severe hypertension
Severe coronary artery disease or ischemic heart disease
Use within 14 days of MAO inhibitor
Narrow-angle glaucoma
Urinary retention
Peptic ulcer
During asthma attack
Treatment of lower respiratory tract conditions, including asthma
Precautions
Brompheniramine: May cause significant confusional symptoms; not for administration to premature or full-term neonates
Dextromethorphan: Do not take for persistent or chronic cough associated with smoking, asthma, or emphysema, or if it is accompanied by excessive phlegm unless directed by a healthcare provider; may decrease respiration rate
Phenylephrine: Caution in elderly patients, hyperthyroidism, myocardial disease, bradycardia, partial heart block or severe arteriosclerosis
Pregnancy-Lactation
Not Classi
Pregnancy
Animal reproduction studies not conducted; also not known whether drug combination can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; medication should be given to a pregnant woman only if clearly needed
Lactation
Because of higher risk of intolerance of antihistamines in small infants generally, and in newborns and prematures in particular, this medication is contraindicated in nursing mothers
Interactions
MAO inhibitors prolong and intensify anticholinergic effects of antihistamines; antihistamines may have additive effects with alcohol and other CNS depressants, eg, hypnotics, sedatives, tranquilizers, antianxiety agents
Drinking alcohol with this medication can cause side effects
Contraindicated (11)
iobenguane I 123
isocarboxazid
linezolid
phenelzine
phenelzine
procarbazine
rasagiline
selegiline transdermal
safinamide
selegiline
tranylcypromine
Adverse Effects
Frequency Not Defined
Dizziness
Drowsiness
Dry mouth, throat, and nose
Thickening of mucus in nose or throat GI disturbances
Reflex tachycardia
Excitability
Restlessness
Headache
Hypertension
Severe peripheral and visceral vasoconstriction
Mechanism of Action
Brompheniramine: Competitively blocks histamine from binding to H1 receptors; significant antimuscarinic activity and penetrates CNS, which causes pronounced tendency to induce sedation
Dextromethorphan: Cough suppressant that acts centrally on the cough center in medulla
Phenylephrine: Vasoconstrictor & decongestant that relieves symptoms resulting from irritation of upper respiratory tract tissue; shrinks swollen mucous membranes, reduces nasal congestion and tissue hyperemia